GEN Exclusives

More »

GEN News Highlights

More »
Nov 24, 2008

XDx to Restructure

  • XDx is reprioritizing its business efforts. The firm will increase its research, development, and commercial activities in support of AlloMap®. In addition, it will restructure its internal development program, pursue external research collaborations in lupus, as well as suspend development activities in lung transplant. A staff reduction of 25 positions and other cost-saving measures will be undertaken as well.


Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »